Article Listing - Almirall's Axert/Almogran approved for adolescents in the USA

MEDEVA'S ROAD TO SUCCESS

16 March 1992

Ahead of the company's 1991 financal results, which are due out next week, there has been a variety of comment...

VIETNAM PHARMA PRODUCTION STRONG

16 March 1992

A recent meeting on pharmaceutical production in provinces in southern Vietnam in 1991 concluded that the year was a highly...

FRENCH, GERMAN, SWISS HEALTH CARE COSTS

16 March 1992

Health care spending continues to rise remorselessly in Germany and France, although control measures are having partial success.

New figures from...

PRODUCTION STOPS AT POLISH PLANT

16 March 1992

Production at the Rzeszow factory of the Polfa pharmaceutical enterprise has stopped, because the facility has not received $23 million...

GERMANY'S HOECHST, BAYER PROFITS DOWN

16 March 1992

German chemical/pharmaceutical groups reporting 1991 results last week, despite profit declines and dividend cuts, saw their share prices rise.

Among...

NOVO REPORTS 28% PRETAX PROFIT JUMP

16 March 1992

Danish drugmaker Novo Nordisk saw 1991 pretax income jump 28% to 1.46 billion Danish kroner ($226.4 million), on sales up...

TAMOXIFEN TRIAL IN MEN

16 March 1992

- Imperial Chemical Indus-tries' Nolvadex (tamoxifen) is prolonging the lives of men with breast cancer, according to results of a...

US APPRO FOR ISIS' ANTISENSE TRIAL

16 March 1992

- Isis Pharma has received US Food and Drug Administration approval to begin human clinical trials with an anti-sense compound....

COMBO THERAPY FOR LEISHMANIASIS

16 March 1992

- The combination of allopurinol and meglumine antimoniate is more effective than the latter alone for American cutaneous leishmaniasis, according...

SANDOZ' NEW US RESEARCH CENTER

16 March 1992

- Sandoz Pharma has opened a new $50 million, 167,000 square foot research center in East Hanover, New Jersey, to...